On September 1, Camilla Wiberg will take up the newly established position as Chief HR Officer (CHRO) and become a member of the Devyser group management. In Devyser’s current growth…
On Wednesday August 24, at 09.00 CET, Devyser Diagnostics AB will host an online presentation of its Q2 2022 interim report (which will have been published earlier on August 24, at 08.00…
Devyser has been awarded a tender from Héma-Québec, in Québec, Canada, for its non-invasive fetal RHD detection product, used to determine fetal RHD status from maternal plasma in early…
The Annual General Meeting of Devyser Diagnostics AB (publ) (“Devyser” or the “Company”) was held on Wednesday, 11 May 2022. The Annual General Meeting was conducted by way of postal…
"Despite a turbulent environment, we are pleased that the first quarter of 2022 has continued in the same positive direction as we saw in 2021. Both sales and gross margin set new records…
On Wednesday May 11, at 09.00 CET, Devyser Diagnostics AB will host an online presentation of its Q1 2022 interim report (which will have been published earlier on May 11, at 08.00 CET).…
Devyser announces a strengthening of its commercial organization with the appointment of Theis Kipling as Chief Commercial Officer (CCO) with global responsibility for sales, marketing,…
Devyser´s annual report 2021 has today been published on the company´s website.
The report is available on: https://investors.devyser.com/en/reports-presentations
The financial year…
Another record quarter
"Devyser’s sales were also strong in the fourth quarter 2021, as well as in the other quarters of the year. We have continued to feel the impact of the pandemic,…
On Thursday February 24, at 09.00 CET, Devyser Diagnostics AB will host a conference call and an online presentation of its Q4 2021 interim report (which will have been published earlier…
